Now that there is an approved therapy for seborrheic dermatitis, it is time to give this condition the attention and respect ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

Atopic dermatitis, a chronic skin condition, is common in children and requires treatment to minimise frequent flares. Dr Ker ...

Pharmaceutical firms are urged to capitalise on current trends in AD trials. The atopic dermatitis (AD) market is projected ...

Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

异位性皮肤炎不仅会伤害患者的皮肤，也可能影响生活质量和日常活动。新加坡中央医院将在9月13日（星期五）举办“异位性皮肤炎——不止是皮肤表层问题”（Atopic Dermatitis – More than skin deep?）线上英语讲座。

The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...

中国网9月14日讯（记者王一辰）9 月 14 日是第七个的“世界特应性皮炎日” (World Atopic Dermatitis ...

Dupilumab decreases general and type 2 inflammatory biomarker levels in children with moderate to severe atopic dermatitis.

Elanco Animal Health Inc. (ELAN) announced the U.S. Food and Drug Administration has approved Zenrelia, a convenient once-daily oral ...